Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Trulieve Cannabis (TCNNF) EPS (Weighted Average and Diluted) (2020 - 2026)

Trulieve Cannabis has reported EPS (Weighted Average and Diluted) over the past 6 years, most recently at -$0.23 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 14.81% year-over-year to -$0.23; the TTM value through Dec 2025 reached -$0.57, up 27.85%, while the annual FY2025 figure was -$0.58, 26.58% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.23 at Trulieve Cannabis, down from -$0.11 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.31 in Q2 2021 and troughed at -$1.8 in Q2 2023.
  • A 5-year average of -$0.22 and a median of -$0.16 in 2022 define the central range for EPS (Weighted Average and Diluted).
  • Biggest five-year swings in EPS (Weighted Average and Diluted): crashed 4800.0% in 2021 and later soared 97.78% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.47 in 2021, then skyrocketed by 31.91% to -$0.32 in 2022, then skyrocketed by 40.63% to -$0.19 in 2023, then tumbled by 42.11% to -$0.27 in 2024, then grew by 14.81% to -$0.23 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for TCNNF at -$0.23 in Q4 2025, -$0.11 in Q3 2025, and -$0.07 in Q2 2025.